Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris S Probert

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Inflammatory Bowel Diseases|September 26, 2008
Are there any ethnic groups that are more likely to develop IBD?Chris S Probert, Matt Brown
The Journal of Family Practice|November 25, 2010
A costly diagnostic failureArash Assadsangabi, Chris S Probert, Ian Pope
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 12, 2013
The liver breath! Breath volatile organic compounds for the diagnosis of liver diseaseTanzeela Khalid, Paul Richardson, Chris S Probert
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2019
The Proof for Oral Crohn's Disease Is in the Cinnamon-free PuddingBenjamin Crooks, Chris S Probert, Jimmy K Limdi
European Journal of Gastroenterology & Hepatology|February 28, 2008
Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcomeJayshri A Shah, Cathryn M Edwards, Chris S Probert
Alimentary Pharmacology & Therapeutics|May 7, 2020
Review article: impact of cigarette smoking on intestinal inflammation-direct and indirect mechanismsStamatia Papoutsopoulou, Jack Satsangi, Barry J Campbell, et al.
European Journal of Gastroenterology & Hepatology|July 29, 2010
Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazinePia Munkholm, Pierre Michetti, Chris S Probert, et al.
Postgraduate Medical Journal|April 1, 2010
Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatmentRichard Parker, Anindya Dixit, Anyinda Dixit, et al.
Plos One|March 22, 2013
An investigation of fecal volatile organic metabolites in irritable bowel syndromeIftikhar Ahmed, Rosemary Greenwood, Ben de Lacy Costello, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 26, 2016
Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care CohortAshley D Bond, Michael D Burkitt, David Sawbridge, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Inflammatory Bowel Diseases|September 26, 2008
Are there any ethnic groups that are more likely to develop IBD?Chris S Probert, Matt Brown
The Journal of Family Practice|November 25, 2010
A costly diagnostic failureArash Assadsangabi, Chris S Probert, Ian Pope
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 12, 2013
The liver breath! Breath volatile organic compounds for the diagnosis of liver diseaseTanzeela Khalid, Paul Richardson, Chris S Probert
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2019
The Proof for Oral Crohn's Disease Is in the Cinnamon-free PuddingBenjamin Crooks, Chris S Probert, Jimmy K Limdi
European Journal of Gastroenterology & Hepatology|February 28, 2008
Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcomeJayshri A Shah, Cathryn M Edwards, Chris S Probert
Alimentary Pharmacology & Therapeutics|May 7, 2020
Review article: impact of cigarette smoking on intestinal inflammation-direct and indirect mechanismsStamatia Papoutsopoulou, Jack Satsangi, Barry J Campbell, et al.
European Journal of Gastroenterology & Hepatology|July 29, 2010
Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazinePia Munkholm, Pierre Michetti, Chris S Probert, et al.
Postgraduate Medical Journal|April 1, 2010
Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatmentRichard Parker, Anindya Dixit, Anyinda Dixit, et al.
Plos One|March 22, 2013
An investigation of fecal volatile organic metabolites in irritable bowel syndromeIftikhar Ahmed, Rosemary Greenwood, Ben de Lacy Costello, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 26, 2016
Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care CohortAshley D Bond, Michael D Burkitt, David Sawbridge, et al.
Pageof 3